Review: hemoglobin-based blood substitutes increase mortality and myocardial infarction in surgical, trauma, and stroke settings
- PMID: 19014171
Review: hemoglobin-based blood substitutes increase mortality and myocardial infarction in surgical, trauma, and stroke settings
Comment on
-
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.JAMA. 2008 May 21;299(19):2304-12. doi: 10.1001/jama.299.19.jrv80007. Epub 2008 Apr 28. JAMA. 2008. PMID: 18443023 Free PMC article.
Similar articles
-
Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program.Am Heart J. 2009 Mar;157(3):495-501. doi: 10.1016/j.ahj.2008.11.009. Epub 2009 Jan 8. Am Heart J. 2009. PMID: 19249420
-
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.J Am Coll Surg. 2009 Jan;208(1):1-13. doi: 10.1016/j.jamcollsurg.2008.09.023. Epub 2008 Nov 7. J Am Coll Surg. 2009. PMID: 19228496 Clinical Trial.
-
HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.J Trauma. 2009 Feb;66(2):365-76. doi: 10.1097/TA.0b013e3181820d5c. J Trauma. 2009. PMID: 19204509 Clinical Trial.
-
Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?Crit Care Clin. 2009 Apr;25(2):279-301, Table of Contents. doi: 10.1016/j.ccc.2009.01.003. Crit Care Clin. 2009. PMID: 19341909 Review.
-
Hemoglobin-based oxygen carriers: current status and future directions.Anesthesiology. 2009 Nov;111(5):946-63. doi: 10.1097/ALN.0b013e3181ba3c2c. Anesthesiology. 2009. PMID: 19858869 Review. No abstract available.